Zoledronic Acid as Adjuvant Therapy in Neovascular Age-related Macular Degeneration (Z-AMD)
Clinical trial NCT04304755 · COMPLETED
Trial details
- NCT number
- NCT04304755
- Sponsor
- Oslo University Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-25
- Primary completion
- 2024-01-24
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.